Emergent BioSolutions Inc. Total Assets

• Emergent BioSolutions Inc. showed a decrease of -23.8% in Total Assets from 2023 to 2024.
• This data is from Emergent BioSolutions Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2025.
• XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2011: $493.98 million | Q3 2011: $512.96 million | Q1 2012: $514.69 million | Q2 2012: $527.14 million | Q3 2012: $540.03 million | Q1 2013: $538.39 million | Q2 2013: $555.61 million | Q3 2013: $595.46 million | Q1 2014: $823.25 million | Q2 2014: $837.25 million | Q3 2014: $869.29 million | Q1 2015: $917.85 million | Q2 2015: $943.32 million | Q3 2015: $976.55 million | Q1 2016: $1.04 billion | Q2 2016: $1.06 billion | Q3 2016: $932.03 million | Q1 2017: $951.64 million | Q2 2017: $970.48 million | Q3 2017: $1.02 billion | Q1 2018: $1.07 billion | Q2 2018: $1.14 billion | Q3 2018: $1.17 billion | Q1 2019: $2.15 billion | Q2 2019: $2.32 billion | Q3 2019: $2.33 billion | Q1 2020: $2.28 billion | Q2 2020: $2.47 billion | Q3 2020: $2.62 billion | Q1 2021: $2.90 billion | Q2 2021: $2.92 billion | Q3 2021: $2.87 billion | Q1 2022: $2.78 billion | Q2 2022: $2.74 billion | Q3 2022: $2.90 billion | Q1 2023: $2.95 billion | Q2 2023: $2.18 billion | Q3 2023: $1.89 billion | Q1 2024: $1.80 billion | Q2 2024: $1.51 billion | Q3 2024: $1.48 billion | Q4 2024: $1.39 billion | Q1 2025: $1.43 billion | Q2 2025: $1.42 billion | Q3 2025: $1.46 billion.
• Over the full 15 years of available data (2010 to 2024), Emergent BioSolutions Inc.'s Total Assets has grown by 177.8%.
• Historical annual values: Fiscal year 2024: $1.39 billion | Fiscal year 2023: $1.82 billion | Fiscal year 2022: $3.17 billion | Fiscal year 2021: $2.96 billion | Fiscal year 2020: $2.88 billion | Fiscal year 2019: $2.33 billion | Fiscal year 2018: $2.23 billion | Fiscal year 2017: $1.07 billion | Fiscal year 2016: $970.11 million | Fiscal year 2015: $1.04 billion | Fiscal year 2014: $938.69 million | Fiscal year 2013: $626.63 million | Fiscal year 2012: $564.23 million | Fiscal year 2011: $546.86 million | Fiscal year 2010: $500.32 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026